Has Parag Joshi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,827 in general payments to Parag Joshi, MD across 7 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Parag Joshi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Parag Joshi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Parag Joshi, MD

Cardiovascular Disease · Dallas, TXNPI 1275710402

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,525 of the $7,827 with a category attached, or 96.1%. Novartis accounts for 97.5% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $3,749, more than ten times the $69 reported in 2019.

$7,827in general payments, 2019–2025

Across 7 payments — averaging $1118.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$8K
Merck$91
Abbott$69
Abiomed$33

$1,389,954in research payments, 2019–2025

Across 55 payments — averaging $25,272 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novo Nordisk$1.1M
Eli Lilly$180K
Novartis$93K
AstraZeneca$38K
Astrazeneca UK Limited$20K
GSK$2K

What the payments were for

Consulting fees$7,52596%
Food & beverage$3024%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	4	$7,633
Merck	1	$91
Abbott	1	$69
Abiomed	1	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LEQVIO$1,608

How this compares

$7,827 in reported general payments places this provider in the 70th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Medicare billing

Part B allowed, 2024

$97,952

Medicare patients

1,537

Services billed

3,038

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	117	$109,334
JardianceEmpagliflozin	32	$37,994
EliquisApixaban	22	$27,923
Praluent PenAlirocumab	23	$24,486
Dofetilide	11	$1,750
Atorvastatin Calcium	138	$1,731
Ezetimibe	51	$1,354
Metoprolol Succinate	50	$936
Rosuvastatin Calcium	46	$582
Losartan Potassium	46	$419
Hydralazine Hcl	15	$270
Carvedilol	27	$258
Isosorbide Mononitrate ErIsosorbide Mononitrate	20	$242
Lisinopril	22	$238
Amlodipine Besylate	35	$198

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Dallas

Ramin Farzaneh-FarDallas$17.1M
Darren McGuireDallas$1.2M
Peter McCulloughDallas$664K
Ann NavarDallas$616K
Milton PackerDallas$530K
Amarinder BindraDallas$512K
Ambarish PandeyDallas$325K
Eric PetersonDallas$187K
Brittany WeberDallas$186K
James de LemosDallas$181K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →